Hideyuki Kondo

Chiyoda, 1006614, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Impact of Japanese Subpopulation Data and Overall Survival in Pivotal Trials on Oncology Drug Approvals in Japan.

Impact of Japanese Subpopulation Data and Overall Survival in Pivotal Trials on Oncology Drug Approvals in Japan.

Journal: Therapeutic innovation & regulatory science

Published: November 28, 2025

Effectiveness of drug postmarketing all-case surveillance as a safety measure in Japan.

Effectiveness of drug postmarketing all-case surveillance as a safety measure in Japan.

Journal: Therapeutic advances in drug safety

Published: April 15, 2021

Delayed nivolumab-induced hepatotoxicity during pazopanib treatment for metastatic renal cell carcinoma: An autopsy case.

Delayed nivolumab-induced hepatotoxicity during pazopanib treatment for metastatic renal cell carcinoma: An autopsy case.

Journal: IJU case reports

Published: December 18, 2018

Usefulness of Implementing Comprehensive Pharmaceutical Care for Metastatic Renal Cell Carcinoma Outpatients Treated with Pazopanib.

Usefulness of Implementing Comprehensive Pharmaceutical Care for Metastatic Renal Cell Carcinoma Outpatients Treated with Pazopanib.

Journal: Anticancer research

Published: December 15, 2018

Promotion of Japan's participation in global clinical trials.

Promotion of Japan's participation in global clinical trials.

Journal: Drug discovery today

Published: November 30, 2018

A Case of Renal Oncocytoma with Renal Venous Tumor Thrombus.

A Case of Renal Oncocytoma with Renal Venous Tumor Thrombus.

Journal: The Keio journal of medicine

Published: November 27, 2018

Early tumor shrinkage as a predictive factor of metastatic renal cell carcinoma in molecular targeted therapy: A single institutional study.

Early tumor shrinkage as a predictive factor of metastatic renal cell carcinoma in molecular targeted therapy: A single institutional study.

Journal: Molecular and clinical oncology

Published: June 07, 2018

Regulatory/Scientific Supports for Micro-, Small-, and Medium-Sized Enterprises (SMEs) With Medicinal Products Provided by the PMDA and EMA.

Regulatory/Scientific Supports for Micro-, Small-, and Medium-Sized Enterprises (SMEs) With Medicinal Products Provided by the PMDA and EMA.

Journal: Therapeutic innovation & regulatory science

Published: May 04, 2018

What to Know About Medicines With New Active Ingredients Approved in FY 2016 / 2016 in Japan and EU: A Brief Comparison of New Medicines Approved in Japan and the EU in 2016.

What to Know About Medicines With New Active Ingredients Approved in FY 2016 / 2016 in Japan and EU: A Brief Comparison of New Medicines Approved in Japan and the EU in 2016.

Journal: Therapeutic innovation & regulatory science

Published: May 02, 2018

Embolization Using N-butyl Cyanoacrylate for Postoperative Lymphatic Leakage: A Case Report.

Embolization Using N-butyl Cyanoacrylate for Postoperative Lymphatic Leakage: A Case Report.

Journal: Clinical genitourinary cancer

Published: November 29, 2017

Clinical Impact of Consolidative and Salvage Radiotherapy for Lymph Node Metastasis in Upper Urinary Tract Urothelial Carcinoma.

Clinical Impact of Consolidative and Salvage Radiotherapy for Lymph Node Metastasis in Upper Urinary Tract Urothelial Carcinoma.

Journal: Case reports in urology

Published: November 22, 2017

A Comparison of PMDA and EMA Consultations for Regulatory and Scientific Matters in Drugs and Regenerative Medicine Products.

A Comparison of PMDA and EMA Consultations for Regulatory and Scientific Matters in Drugs and Regenerative Medicine Products.

Journal: Therapeutic innovation & regulatory science

Published: May 01, 2017

Showing 1-12 of 13

Last Updated: 09/26/2026